Log in to save to my catalogue

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation...

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a029501cd4ea4989bf6d137ae286835e

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

FOLFIRINOX, a combination of chemotherapy drugs (Fluorouracil, Oxaliplatin, Irinotecan -FOI), provides the best clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients. In this study we explore the role of miRNAs (MIR) as modulators of chemosensitivity to identify potential biomarkers of response. We find that 41 and 84 microRNA inhibi...

Alternative Titles

Full title

Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a029501cd4ea4989bf6d137ae286835e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a029501cd4ea4989bf6d137ae286835e

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-27099-6

How to access this item